Kamada (KMDA)
Develops plasma-derived therapies and distributes biopharmaceutical products in Israel and the MENA region.
$8.75
vs last close−0.12 (−1.35%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
$0.14
Revenue estimate
$52.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.07$0.07$0.13$0.09$0.06$0.07$0.16Pending
Estimate$0.05$0.07$0.09$0.10$0.09$0.12$0.11$0.14
Surprise+40.0%0.0%+44.4%−10.0%−33.3%−41.7%+42.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$39.0M$44.0M$44.8M$47.0M$44.7M$45.2M$54.9MPending
Estimate$152.7M$161.5M$155.0M$147.6M$45.4M$46.7M$50.8M$52.8M
Surprise−74.5%−72.8%−71.1%−68.1%−1.6%−3.2%+8.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.14 | — | — |
| Sep 2027 | $0.14 | — | — |
| Jun 2027 | $0.13 | — | — |
| Mar 2027 | $0.11 | — | — |
| Dec 2026 | $0.13 | — | — |
| Nov 2026 | $0.14 | — | — |
| Aug 2026 | $0.11 | $0.16 | +42.2% |
| May 2026 | $0.12 | $0.07 | −41.7% |
| Mar 2026 | $0.09 | $0.06 | −33.3% |
| Nov 2025 | $0.10 | $0.09 | −10.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.14 | — | — | $54.7M | — | — | — |
| Sep 2027 | $0.14 | — | — | $59.6M | — | — | — |
| Jun 2027 | $0.13 | — | — | $57.6M | — | — | — |
| Mar 2027 | $0.11 | — | — | $47.4M | — | — | — |
| Dec 2026 | $0.13 | — | — | $50.6M | — | — | — |
| Nov 9, 2026 | $0.14 | — | — | $52.8M | — | — | — |
| Aug 12, 2026 | $0.11 | $0.16 | +42.2% | $50.8M | $54.9M | +8.0% | −3.0% |
| May 13, 2026 | $0.12 | $0.07 | −41.7% | $46.7M | $45.2M | −3.2% | −6.8% |
| Mar 11, 2026 | $0.09 | $0.06 | −33.3% | $45.4M | $44.7M | −1.6% | −4.6% |
| Nov 10, 2025 | $0.10 | $0.09 | −10.0% | $147.6M | $47.0M | −68.1% | +5.4% |
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 5, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 6, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 16, 2023 | |||||||
| May 24, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 22, 2022 | |||||||
| Aug 17, 2022 | |||||||
| May 17, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 22, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 12, 2021 | |||||||
| Feb 10, 2021 | |||||||
| Nov 11, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 18, 2020 | |||||||
| Feb 12, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 14, 2019 | |||||||
| Feb 12, 2019 | |||||||
| Nov 12, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 15, 2018 | |||||||
| Feb 7, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Aug 1, 2017 | |||||||
| May 16, 2017 | |||||||
| Feb 6, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 2, 2016 | |||||||
| May 9, 2016 | |||||||
| Feb 2, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Jul 30, 2015 |